← all signals · sectors · research
PUMA BIOTECHNOLOGY, INC. PBYI
SIC 2834 — Pharmaceutical Preparations · CIK 1401667
This page lists every Interactive Market Data signal that fired on this company across fiscal years, with the calibrated net-of-cost forward-return prediction. Predictions use a triple → pair → singles fallback against our backtest panel (~32K (cik × fy) signal combos, net of execution costs at 5 bps half-spread + ADV-tiered borrow).
FY2025 short
2 signals fired ·
match: pair
dso_drift_severe, positive_eps_streak
| Horizon | Predicted net PnL |
|---|---|
| 20 days | +0.34% |
| 60 days | -3.08% |
| 252 days (1y) | -13.91% |
FY2024 long
1 signal fired ·
match: singles_avg
| Horizon | Predicted net PnL |
|---|---|
| 20 days | -1.03% |
| 60 days | +1.48% |
| 252 days (1y) | +13.47% |
FY2023 long
1 signal fired ·
match: singles_avg
| Horizon | Predicted net PnL |
|---|---|
| 20 days | +1.81% |
| 60 days | +4.48% |
| 252 days (1y) | +19.70% |
FY2022 short
3 signals fired ·
match: triple
dso_drift_severe, fcf_ni_divergence, fcf_turn_negative
| Horizon | Predicted net PnL |
|---|---|
| 20 days | +2.21% |
| 60 days | +0.56% |
| 252 days (1y) | -20.70% |
FY2019 long
2 signals fired ·
match: pair
dso_drift_severe, fcf_turn_positive
| Horizon | Predicted net PnL |
|---|---|
| 20 days | +0.69% |
| 60 days | +1.62% |
| 252 days (1y) | +6.76% |
Methodology: /methodology · Live JSON: /api/company/1401667/financials